Electrocardiographic characteristics in a population with high rates of seropositivity for Trypanosoma cruzi infection

American Journal of Tropical Medicine and Hygiene

Volumn 77, Issue 3, 2007, Pages 495-499

  Williams Blangero, S ^a   Magalhaes, T ^b   Rainwater, E ^a   Blangero, J ^a   Correa Oliveira R ^b   VandeBerg, J L ^a,c  

^a SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c SOUTHWEST NATIONAL PRIMATE RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAZIL; CHAGAS DISEASE; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; QRS COMPLEX; QT INTERVAL; QUANTITATIVE ANALYSIS; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS; ANIMAL; BLOOD; HEART DISEASE; IMMUNOLOGY;

TRYPANOSOMA CRUZI;

ANIMALS; BRAZIL; CHAGAS DISEASE; ELECTROCARDIOGRAPHY; FEMALE; HEART DISEASES; HUMANS; MALE; TRYPANOSOMA CRUZI;

EID: 35748948070     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2007.77.495     Document Type: Article

References (36)

1. Dias JC, Silveira AC, Schofield CJ, 2002. Impact of Chagas disease control in Latin America: a review. Mem Inst Oswaldo Cruz 97: 603-612.
2. World Health Organization, 2002. Control of Chagas disease. World Health Organ Tech Rep Ser 905: 1-109.
3. Moncayo A, 2003. Chagas disease: current epidemiological trends after the interruption of vectoral and transfusional transmission in the Southern Cone countries. Mem Inst Oswaldo Cruz 98: 577-591.
4. Dutra WO, Rocha MO, Teixeira MM, 2005. The clinical immunology of human Chagas disease. Trends Parasitol 21: 581-587.
5. Kirchhoff LV, 1999. American trypanosomiasis (Chagas disease). Guerrant RL, Walker DH, Weller PF, eds. Tropical Infectious Diseases: Principles, Pathogens, and Practice. New York: Churchill Livingstone, 785-796.
6. Coll-Cardenas R, Espinoza-Gomez F, Maldonado-Rodriguez A, Reyes-Lopez PA, Huerta-Viera M, Rojas-Larios F, 2004. Active transmission of human Chagas disease in Colima, Mexico. Mem Inst Oswaldo Cruz 99: 363-368.
7. Rizzo NR, Arana BA, Diaz A, Cordon-Rosales C, Klein RE, Powell MR, 2003. Seroprevalence of Trypanosoma cruzi infection among school-age children in the endemic area of Guatemala. Am J Trop Med Hyg 68: 678-682.
8. Grijalva MJ, Escalante L, Paarades RA, Costales JA, Padilla A, Rowland EC, Aguilar JM, Racines J, 2003. Seroprevalence and risk factors for Trypanosoma cruzi infection in the Amazon region of Ecuador. Am J Trop Med Hyg 69: 380-385.
9. Pinto AY, Valente SA, Valente VC, 2004. Emerging acute Chagas disease in Amazonian Brazil: case reports with serious cardiac involvement. Braz J Infect Dis 8: 454-460.
10. Gurtler RE, Cecere MC, Lauricella MA, Petersen RM, Chuit R, Segura EL, Cohen JE, 2005. Incidence of Trypanosoma cruzi infection among children following domestic reinfestation after insecticide spraying in rural northwestern Argentina. Am J Trop Med Hyg 73: 95-103.
11. Borges JS, Machada de Assis GF, Gomes LV, Dias JC, Pinto ID, Martins-Filho OA, Torres RM, Vinas PA, Bahia MT, Machado-Coelho GL, Lana M, 2006. Seroprevalence of Chagas disease in school children from two municipalities of Jequitinhonha Valley, Minas Gerais, Brazil: six years following the onset of epidemiological surveillance. Rev Inst Med Trop Sao Paulo 48: 81-86.
12. Garg N, Bhatia V, 2005. Current status and future prospects for a vaccine against American trypanosomiasis. Expert Rev Vaccines 4: 867-880.
13. Urbino JA, Docompo R, 2004. Specific chemotherapy of Chagas disease: controversies and advances. Trends Parasitol 19: 495-501.
14. Kirchhoff LV, 2003. Changing epidemiology and approaches to therapy for Chagas disease. Curr Infect Dis Rep 5: 59-65.
15. McCarthy M, 2003. American Red Cross to screen blood for Chagas disease. Lancet 362: 1988.
16. Busch MP, Kleinman SH, Nemo GJ, 2003. Current and emerging infectious risks of blood transfusions. JAMA 289: 959-961.
17. Beard CB, Pye G, Steurer FJ, Rodrigues R, Campman R, Peterson AT, Ramsey J, Wirtz RA, Robinson LE, 2003. Chagas disease in a domestic transmission cycle, southern Texas, USA. Emerg Infect Dis 9: 103-105.
18. DiPentima MC, Hwang LY, Skeeter CM, Edwards MS, 1999. Prevalence of antibody to Trypanosoma cruzi in pregnant Hispanic women in Houston. Clin Infect Dis 28: 1281-1285.
19. Leiby DA, Herron RM, Read EJ, Lenes BA, Stumpf RJ, 2002. Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission. Transfusion 42: 549-555.
20. Centers for Disease Control and Prevention, 2002. Chagas disease after organ transplantation - United States, 2001. MMWR Morb Mortal Wkly Rep 51: 210-212.
21. Kirchhoff LV, Weiss LM, Wittner M, Tanowitz HB, 2004. Parasitic diseases of the heart. Front Biosci 9: 706-723.
22. Prata A, 2001. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis 1: 92-100.
23. Goldbaum M, Ajimura FY, Litvoc J, Alves de Carvalho S, Eluf-Neto J, 2004. American trypansomiasis and electrocardiographic alterations among industrial workers in Sao Paulo, Brazil. Rev Inst Med Trop Sao Paulo 46: 299-302.
24. Yacoub S, Birks EJ, Slavik Z, Henein M, 2003. Early detection of myocardial dysfunction in Chagas disease using novel echocardiographic indices. Trans R Soc Trop Med Hyg 97: 528-534.
25. Sosa-Hurado F, Mazariego-Aranda M, Hernandez-Becerril N, Garza-Murillo V, Cardenas M, Reyes PA, Hirayama K, Monteon VM, 2003. Electrocardiographic findings in Mexican Chagasic subjects living in high and low endemic regions of Trypansoma cruzi infection. Mem Inst Oswaldo Cruz 98: 605-610.
26. Rangel-Flores H, Sánchez B, Mendoza-Duarte J, Barbnabe C, Breniere FS, Ramos C, Espinoza B, 2001. Serologic and parasitologic demonstration of Trypansoma cruzi infections in an urban area of central Mexico: correlation with electrocardiographic alterations. Am J Trop Med Hyg 65: 887-895.
27. Jorge MT, Macedo TA, Janones RS, Carizzi DP, Heredia RA, Acha RE, 2003. Types of arrhythmia among cases of American trypanosomiasis compared with those in other cardiology patients. Ann Trop Med Parasitol 97: 139-148.
28. Maguire JH, Hoff R, Sherlock I, Guimaraes AC, Sleigh AC, Ramos NB, Mott KE, Weller TH, 1987. Cardiac morbidity and mortality due to Chagas disease: prospective electrocardiographic study of a Brazilian community. Circulation 75: 1140-1145.
29. Salles G, Xavier S, Sousa A, Hasslocher-Moreno A, Cardosa C, 2003. Prognostic value of QT interval parameters for mortality risk stratification in Chagas disease: results of a long-term follow-up study. Circulation 108: 305-312.
30. Salles G, Xavier S, Sousa A, Hasslocher-Moreno A, Cardosa C, 2004. T-wave axis deviation as an independent predictor of mortality in chronic Chagas disease. Am J Cardiol 93: 1136-1140.
31. Almasy L, Blangero J, 1998. Multipoint quantitative trait linkage analysis in general pedigrees. Am J Hum Genet 62: 1198-1211.
32. Brutus L, Schneider D, Postigo J, Delgado W, Mollinedo S, Chippaux JP, 2007. Evidence of congenital transmission of Trypanosoma cruzi in a vector-free area of Bolivia. Trans R Soc Trop Med Hyg: (Epub ahead of print).
33. Corbucci HA, Haber DM, Bestetti RB, Cordeiro JA, Fioroni ML, 2006. QT interval dispersion in patients with chronic heart failure secondary to Chagas cardiomyopathy: correlation with clinical variables of prognostic significance. Cardiovasc Pathol 15: 18-23.
34. Soto-Rojas G, Cortes JM, Medrano GA, 1984. Electrocardiographic changes in 29 apparently healthy subjects with positive serological tests for Chagas disease. Arch Inst Cardiol Mex 54: 579-583.
35. Pimenta J, Miranda M, Pereira CB, 1983. Electrophysiologic findings in long-term asymptomatic chagasic individuals. Am Heart J 106: 374-380.
36. DeBacquer D, DeBacker G, Kornitzer M, 2000. Prevalences of ECG findings in large population based samples of men and women. Heart 84: 625-633.